Dishman Carbogen Amcis Limited (DCAL.BO)
INR 211.0
(0.12%)
INR 211.0
(0.12%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -13.9 Million INR | -131.46% |
| 2022 | 774.3 Million INR | 1133.78% |
| 2021 | -74.9 Million INR | 71.51% |
| 2020 | -262.9 Million INR | -113.63% |
| 2019 | 1.92 Billion INR | -8.97% |
| 2018 | 2.11 Billion INR | -4.57% |
| 2017 | 2.22 Billion INR | 24.31% |
| 2016 | 1.78 Billion INR | -33.45% |
| 2015 | 2.68 Billion INR | 12.77% |
| 2014 | 2.38 Billion INR | 4.7% |
| 2013 | 2.27 Billion INR | 5.0% |
| 2012 | 2.16 Billion INR | 42.01% |
| 2011 | 1.52 Billion INR | 3.89% |
| 2010 | 1.46 Billion INR | -14.32% |
| 2009 | 1.71 Billion INR | -13.83% |
| 2008 | 1.98 Billion INR | 103.81% |
| 2007 | 975.34 Million INR | 15.77% |
| 2006 | 842.46 Million INR | 59.61% |
| 2005 | 527.81 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -470.6 Million INR | -110.84% |
| 2023 Q4 | -223.2 Million INR | 32.79% |
| 2023 Q3 | -332.1 Million INR | -92.63% |
| 2023 FY | -243.6 Million INR | -131.46% |
| 2023 Q1 | 514.1 Million INR | 311.56% |
| 2023 Q2 | -172.4 Million INR | -133.53% |
| 2022 Q2 | -9.7 Million INR | -107.34% |
| 2022 Q1 | 132.1 Million INR | 121.35% |
| 2022 FY | 774.3 Million INR | 1133.78% |
| 2022 Q4 | -243 Million INR | -138.24% |
| 2022 Q3 | 635.4 Million INR | 6650.52% |
| 2021 Q1 | 259.3 Million INR | 123.34% |
| 2021 Q2 | 226.8 Million INR | -12.53% |
| 2021 Q3 | 345.5 Million INR | 52.34% |
| 2021 Q4 | -618.8 Million INR | -279.1% |
| 2021 FY | -74.9 Million INR | 71.51% |
| 2020 Q2 | 165.9 Million INR | 175.34% |
| 2020 Q3 | -75.2 Million INR | -145.33% |
| 2020 Q4 | 116.1 Million INR | 254.39% |
| 2020 Q1 | -220.2 Million INR | -130.11% |
| 2020 FY | -262.9 Million INR | -113.63% |
| 2019 Q3 | 621.2 Million INR | -24.59% |
| 2019 Q1 | 607.1 Million INR | -39.45% |
| 2019 FY | 1.92 Billion INR | -8.97% |
| 2019 Q2 | 823.8 Million INR | 35.69% |
| 2019 Q4 | 731.2 Million INR | 17.71% |
| 2018 Q3 | 884.2 Million INR | 2.72% |
| 2018 FY | 2.11 Billion INR | -4.57% |
| 2018 Q4 | 1 Billion INR | 13.39% |
| 2018 Q2 | 860.8 Million INR | 18.31% |
| 2018 Q1 | 727.6 Million INR | -15.55% |
| 2017 Q2 | 874.3 Million INR | 247.36% |
| 2017 Q3 | 808.6 Million INR | -7.51% |
| 2017 Q4 | 861.6 Million INR | 6.55% |
| 2017 FY | 2.22 Billion INR | 24.31% |
| 2017 Q1 | 251.7 Million INR | -72.94% |
| 2016 FY | 1.78 Billion INR | -33.45% |
| 2016 Q4 | 930.1 Million INR | 47.49% |
| 2016 Q1 | 585.9 Million INR | -1.6% |
| 2016 Q2 | 707.7 Million INR | 20.79% |
| 2016 Q3 | 630.6 Million INR | -10.89% |
| 2015 Q4 | 595.4 Million INR | -26.78% |
| 2015 Q2 | 684.5 Million INR | -18.06% |
| 2015 Q1 | 835.4 Million INR | 24.73% |
| 2015 FY | 2.68 Billion INR | 12.77% |
| 2015 Q3 | 813.2 Million INR | 18.8% |
| 2014 FY | 2.38 Billion INR | 4.7% |
| 2014 Q4 | 669.77 Million INR | 19.08% |
| 2014 Q3 | 562.43 Million INR | -13.2% |
| 2014 Q2 | 647.96 Million INR | 31.4% |
| 2014 Q1 | 493.11 Million INR | -8.88% |
| 2013 Q2 | 711.72 Million INR | 12.36% |
| 2013 FY | 2.27 Billion INR | 5.0% |
| 2013 Q4 | 541.16 Million INR | 35.51% |
| 2013 Q3 | 399.36 Million INR | -43.89% |
| 2013 Q1 | 633.4 Million INR | 15.03% |
| 2012 Q3 | 487.12 Million INR | 3.87% |
| 2012 Q4 | 550.66 Million INR | 13.04% |
| 2012 FY | 2.16 Billion INR | 42.01% |
| 2012 Q2 | 468.96 Million INR | -29.89% |
| 2012 Q1 | 668.88 Million INR | -19.64% |
| 2011 Q3 | 308.73 Million INR | 0.0% |
| 2011 FY | 1.52 Billion INR | 3.89% |
| 2011 Q4 | 832.39 Million INR | 169.62% |
| 2010 FY | 1.46 Billion INR | -14.32% |
| 2009 FY | 1.71 Billion INR | -13.83% |
| 2008 FY | 1.98 Billion INR | 103.81% |
| 2007 FY | 975.34 Million INR | 15.77% |
| 2006 FY | 842.46 Million INR | 59.61% |
| 2005 FY | 527.81 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 9.28 Million INR | 249.736% |
| Biocon Limited | 50.83 Billion INR | 100.027% |
| Blue Jet Healthcare Limited | 3.37 Billion INR | 100.412% |
| Concord Biotech Limited | 6.26 Billion INR | 100.222% |
| FERMENTA BIOTECH LIMITED | 1.06 Billion INR | 101.302% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.27 Million INR | 1189.555% |
| Lyka Labs Limited | 29.13 Million INR | 147.717% |
| Panacea Biotec Limited | -309.7 Million INR | 95.512% |
| SAMSRITA LABS LIMITED | -1.49 Million INR | -828.288% |
| Servoteach Industries Limited | -785.00 INR | -1770600.637% |
| SMS Lifesciences India Limited | 359.47 Million INR | 103.867% |
| Supriya Lifescience Limited | 1.57 Billion INR | 100.884% |
| Syngene International Limited | 14.02 Billion INR | 100.099% |
| TAKE Solutions Limited | -213.49 Million INR | 93.489% |
| Titan Biotech Limited | 315.89 Million INR | 104.4% |
| Transgene Biotek Limited | -7.08 Million INR | -96.078% |
| Vanta Bioscience Limited | -31.83 Million INR | 56.341% |